<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="184996">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00685659</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA020623</org_study_id>
    <secondary_id>R01DA020623</secondary_id>
    <nct_id>NCT00685659</nct_id>
  </id_info>
  <brief_title>Effectiveness of Extended Treatments for Drug Dependence</brief_title>
  <acronym>ETDD</acronym>
  <official_title>Effectiveness of Extended Treatments for Drug Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tests the effectiveness of two 24 month, telephone-based adaptive continuing care
      interventions for patients with cocaine dependence. The two interventions are predicted to
      produce better drug use outcomes than standard care. Furthermore, the intervention that also
      includes monetary incentives for continued participation is hypothesized to produce better
      retention and drug use outcomes than the intervention without incentives. Economic analyses
      will determine the cost-effectiveness and benefit-cost of the interventions relative to
      standard care, and to each other.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is considerable evidence that treatment for drug use disorders can lead to substantial
      improvements in substance use and psychosocial problem severity. However, a significant
      percentage of patients relapse to problematic levels of substance use after primary
      treatment, and require additional treatment episodes. Patients are therefore frequently
      referred to continuing care programs to prevent relapse and decrease the probability of
      additional rehabilitation treatments. However, current models of continuing care may not be
      adequate for the long-term management of a chronic, relapsing disorder such as substance
      dependence. One possible approach for improving the management of drug dependence is
      adaptive treatment regimes, which combine low intensity monitoring and counseling when
      patients are doing well with stepped care protocols to increase the intensity of treatment
      when warranted by deteriorations in status and functioning. However, addiction management
      protocols may require incentives and other features to make long-term participation more
      appealing.

      Cocaine dependent patients who have completed 2 weeks of intensive outpatient treatment
      (IOP) will be randomly assigned to one of the following interventions: (1) continued
      participation in IOP without additional intervention (TAU); (2) TAU plus an adaptive
      protocol that includes monitoring, feedback, and brief counseling via telephone on a tapered
      schedule out to 24 months, and more intensive face-to-face treatment when warranted (TMAC);
      or (3) TAU and the adaptive protocol, plus incentives for sustained participation
      (TMAC-Plus). Patients will be followed up at 3, 6, 9, 12, 18, and 24 months post intake into
      the study. Follow-up assessments will include measures of drug use, treatment process and
      potential mediating factors, psychosocial problem severity, utilization of health and social
      services, and costs.

      The two adaptive extended interventions (TMAC and TMAC-Plus) are predicted to produce better
      drug use outcomes than TAU. TMAC-Plus is hypothesized to produce better retention and drug
      use outcomes than TMAC. Economic analyses will determine the cost-effectiveness and
      benefit-cost of TMAC and TMF-Plus relative to TAU, and to each other. Other analyses will
      test mediation hypotheses, examine potential moderator effects, and test the impact of
      disease management on HIV risk behaviors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abstinence From Cocaine, Alcohol, and Other Drugs.</measure>
    <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Days Cocaine Use</measure>
    <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cocaine Urine Toxicology Results</measure>
    <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">332</enrollment>
  <condition>Cocaine Dependence</condition>
  <arm_group>
    <arm_group_label>TAU only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control condition that consists of treatment as usual, which is Intensive Outpatient Treatment (about 3 months long)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TMAC only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adaptive telephone-based counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TMAC plus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adaptive telephone-based counseling, plus incentives</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensive Outpatient Treatment</intervention_name>
    <description>9 hours of group counseling per week for 2-3 months</description>
    <arm_group_label>TAU only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adaptive telephone-based counseling</intervention_name>
    <description>In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm is included</description>
    <arm_group_label>TMAC only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adaptive telephone-based counseling plus incentives</intervention_name>
    <description>In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm and monetary incentives for participation are included</description>
    <arm_group_label>TMAC plus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  qualify for a DSM-IV lifetime diagnosis of cocaine dependence and cocaine use in 6
             months prior to treatment;

          -  initial engagement in IOP, as indicated by attendance at 4 or more sessions in the
             first two weeks of treatment;

          -  18 to 75 years of age;

          -  willingness to be randomized and participate in research.

          -  metropolitan area residents;

          -  able to provide the name, verified telephone number, and address of at least one
             contact who can provide locator information on the patient during follow-up.

        Exclusion Criteria:

          -  current psychotic disorder or evidence of dementia severe enough to prevent
             participation in outpatient treatment;

          -  acute medical problem requiring immediate inpatient treatment;

          -  current participation in methadone or other forms of DA treatment, other than IOP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James R McKay, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Presbyterian Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthEast Treatment Centers</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>McKay JR, Van Horn DH, Lynch KG, Ivey M, Cary MS, Drapkin ML, Coviello DM, Plebani JG. An adaptive approach for identifying cocaine dependent patients who benefit from extended continuing care. J Consult Clin Psychol. 2013 Dec;81(6):1063-73. doi: 10.1037/a0034265. Epub 2013 Sep 16.</citation>
    <PMID>24041231</PMID>
  </results_reference>
  <results_reference>
    <citation>McKay JR, Van Horn DH, Lynch KG, Ivey M, Cary MS, Drapkin M, Coviello D. Who benefits from extended continuing care for cocaine dependence? Addict Behav. 2014 Mar;39(3):660-8. doi: 10.1016/j.addbeh.2013.11.019. Epub 2013 Dec 1.</citation>
    <PMID>24355401</PMID>
  </results_reference>
  <results_reference>
    <citation>McKay JR, Van Horn D, Rennert L, Drapkin M, Ivey M, Koppenhaver J. Factors in sustained recovery from cocaine dependence. J Subst Abuse Treat. 2013 Aug;45(2):163-72. doi: 10.1016/j.jsat.2013.02.007. Epub 2013 Apr 2.</citation>
    <PMID>23561331</PMID>
  </results_reference>
  <results_reference>
    <citation>Van Horn DH, Drapkin M, Ivey M, Thomas T, Domis SW, Abdalla O, Herd D, McKay JR. Voucher incentives increase treatment participation in telephone-based continuing care for cocaine dependence. Drug Alcohol Depend. 2011 Apr 1;114(2-3):225-8. doi: 10.1016/j.drugalcdep.2010.09.007. Epub 2010 Nov 1.</citation>
    <PMID>21041041</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 20, 2016</lastchanged_date>
  <firstreceived_date>May 23, 2008</firstreceived_date>
  <firstreceived_results_date>February 15, 2016</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cocaine dependence</keyword>
  <keyword>treatment</keyword>
  <keyword>continuing care</keyword>
  <keyword>outcomes</keyword>
  <keyword>incentives</keyword>
  <keyword>adaptive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment as Usual</title>
          <description>Control condition that consists of treatment as usual, which is Intensive Outpatient Treatment (about 3 months long)
Intensive Outpatient Treatment: 9 hours of group counseling per week for 2-3 months</description>
        </group>
        <group group_id="P2">
          <title>TMAC</title>
          <description>Adaptive telephone-based counseling
Adaptive telephone-based counseling: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm is included</description>
        </group>
        <group group_id="P3">
          <title>TMAC Plus</title>
          <description>Adaptive telephone-based counseling, plus incentives
Adaptive telephone-based counseling plus incentives: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm and monetary incentives for participation are included</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
                <participants group_id="P2" count="106"/>
                <participants group_id="P3" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
                <participants group_id="P2" count="81"/>
                <participants group_id="P3" count="92"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment as Usual</title>
          <description>Control condition that consists of treatment as usual, which is Intensive Outpatient Treatment (about 3 months long)
Intensive Outpatient Treatment: 9 hours of group counseling per week for 2-3 months</description>
        </group>
        <group group_id="B2">
          <title>TMAC</title>
          <description>Adaptive telephone-based counseling
Adaptive telephone-based counseling: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm is included</description>
        </group>
        <group group_id="B3">
          <title>TMAC Plus</title>
          <description>Adaptive telephone-based counseling, plus incentives
Adaptive telephone-based counseling plus incentives: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm and monetary incentives for participation are included</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="108"/>
            <count group_id="B2" value="106"/>
            <count group_id="B3" value="107"/>
            <count group_id="B4" value="321"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.9" spread="8.0"/>
                    <measurement group_id="B2" value="43.3" spread="7.8"/>
                    <measurement group_id="B3" value="43.4" spread="6.48"/>
                    <measurement group_id="B4" value="43.2" spread="7.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="83"/>
                    <measurement group_id="B4" value="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="104"/>
                    <measurement group_id="B4" value="308"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="98"/>
                    <measurement group_id="B4" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="107"/>
                    <measurement group_id="B4" value="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Abstinence From Cocaine, Alcohol, and Other Drugs.</title>
        <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment as Usual</title>
            <description>Control condition that consists of treatment as usual, which is Intensive Outpatient Treatment (about 3 months long)
Intensive Outpatient Treatment: 9 hours of group counseling per week for 2-3 months</description>
          </group>
          <group group_id="O2">
            <title>TMAC</title>
            <description>Adaptive telephone-based counseling
Adaptive telephone-based counseling: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm is included</description>
          </group>
          <group group_id="O3">
            <title>TMAC Plus</title>
            <description>Adaptive telephone-based counseling, plus incentives
Adaptive telephone-based counseling plus incentives: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm and monetary incentives for participation are included</description>
          </group>
        </group_list>
        <measure>
          <title>Abstinence From Cocaine, Alcohol, and Other Drugs.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Days Cocaine Use</title>
        <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cocaine Urine Toxicology Results</title>
        <time_frame>at baseline, and 3, 6, 9, 12, 18, and 24 mo follow-ups</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treatment as Usual</title>
          <description>Control condition that consists of treatment as usual, which is Intensive Outpatient Treatment (about 3 months long)
Intensive Outpatient Treatment: 9 hours of group counseling per week for 2-3 months</description>
        </group>
        <group group_id="E2">
          <title>TMAC</title>
          <description>Adaptive telephone-based counseling
Adaptive telephone-based counseling: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm is included</description>
        </group>
        <group group_id="E3">
          <title>TMAC Plus</title>
          <description>Adaptive telephone-based counseling, plus incentives
Adaptive telephone-based counseling plus incentives: In addition to IOP, patients receive telephone counseling calls, in which risk level is assessed and coping skills intervention delivered to address risk areas. Adaptive stepped care algorithm and monetary incentives for participation are included</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="106"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="107"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="106"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="107"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>James R. McKay, Ph.D.</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215-746-7704</phone>
      <email>jimrache@mail.med.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
